Vimarsana
Biggest News Aggregation in the World

Page 3 - Crosslink Life Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crosslink Life Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crosslink Life Sciences Today - Breaking & Trending Today

Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session - Altimmune (NASDAQ:ALT), Annexon (NASDAQ:ANNX) - Vimarsana News

Harpoon Therapeutics, Heron Therapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session - Altimmune (NASDAQ:ALT), Annexon (NASDAQ:ANNX)

Published: January 8, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 150 points on Monday. Shares of Harpoon Therapeutics, Inc.(NASDAQ: HARP) rose sharply in pre-market trading. Bloomberg reported that Merck is in advanced talks to buy Harpoon Therapeutics for $23 per share.

Source: benzinga.com
Related Topics:
Altimmune IncDow JonesHarpoon Therapeutics IncNextracker IncAnnexon IncUpwork IncBetter Home Finance Holding CompanyCrosslink Life SciencesCronos Group IncHeron Therapeutics IncHarpoon Therapeutics
Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket - Vimarsana News

Why LumiraDx Shares Are Trading Lower By Over 30%; Here Are 20 Stocks Moving Premarket

Published: January 8, 2024

Shares of LumiraDx Limited (NASDAQ:LMDX) shares fell sharply in pre-market trading. LumiraDx announced its securities will be suspended from tr...

Source: businessinsider.com
Related Topics:
Nanostring CosmxHeart Test Laboratories IncVincerx Pharma IncHarpoon Therapeutics IncBanzai International IncSpectaire Holdings IncCyclacel Pharmaceuticals IncUs AirlinesNanostring Technologies IncSharps Technology IncArena Group Holdings IncAmpio Pharmaceuticals IncFintech Group IncSpirit Aerosystems Holdings IncEnterprises IncGreen Development CorporationEffector Therapeutics IncLumiradx LimitedCrosslink Life SciencesAinos IncHeron Therapeutics IncBrera HoldingsVision Marine Technologies IncHarpoon TherapeuticsMarine Technologies
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain - Vimarsana News

Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain

Published: January 7, 2024

SAN DIEGO, Jan. 7, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership with...

Source: marketscreener.com
Related Topics:
United StatesIra DuarteThomas FleetwoodDrug AdministrationEuropean UnionPrnewswire Heron Therapeutics IncHeron Therapeutics IncCrosslink Life SciencesExchange CommissionCraig CollardChief Executive OfficerEuropean CommissionUnited Kingdom Regulatory AuthorityHeron TherapeuticsPrivate Securities Litigation Reform ActBoxed WarningMedia ContactVice PresidentChief Financial